Benzothiazole derivatives with activity as adenosine receptor ligands
US7317007B2 · kind B2 · utility
2Cited by
12References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2005 |
| Grant date | Jan 8, 2008 |
| Priority date | — |
| Expiry date | Sep 2, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to substituted benzothiazole derivitives and to their pharmaceutically acceptable salts useful for the treatment of diseases related to the adenosine receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.